-
-
-
-
-
-
-
Sanofi acquires rights to plozasiran drug candidate in Greater China
-
-
-
-
-
-
-
Takeda Pharmaceutical (TAK) and Arrowhead (ARWR) Announce Publication of Results from Phase 2 Study of Fazirsiran
-
-
-
-
-
-
-
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Zuora, Arrowhead Pharmaceuticals, ResMed, and Covetrus and Encourages Investors to Contact the Firm
-
-
-
-
-
-
-
Pre-Open 12/03: (BOLD) (VRAY) (ALDX) Higher (CBL) (CARA) (CLF) Lower (more...)
-
-
-
-
-
-
-
Pre-Open Movers 10/04: (BKS) (CLDR) (HDP) Higher; (RTEC) (WLDN) (SNAP) Lower (more...)
-
-
-
-
-
-
-
Arrowhead Research (ARWR) Adopts Stockholder Rights Agreement
-
-
-
-
-
-
-
Pre-Open Stock Movers 8/18: (SEMI) (CIE) (RPTP) Higher; (EARS) (CERU) (PTLA) Lower
-
1,178,427 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

